ClinicalTrials.gg
Sign In

Hyperbilirubinemia clinical trials

The registry lists 81 studies for Hyperbilirubinemia across more than 10 countries. 11 are recruiting or about to start. 22 of them are mainly about Hyperbilirubinemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its 4 narrower conditions too, such as Jaundice, Neonatal: 324 studies, 65 open.

Get an email when these change. Save the Hyperbilirubinemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
51
Recruiting
9
Status unknown
9
Withdrawn
4
Terminated
4
Not yet recruiting
2

Phase

Phase 2
7
Phase 3
5
Phase 4
4
Phase 1
2
Early Phase 1
1

Where

United States
17
Turkey
13
China
11
India
5
Pakistan
4
Brazil
2

Who runs them

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (5) · Nanjing Medical University (4) · All India Institute of Medical Sciences, New Delhi (3) · Assiut University (2) · Pediatrix (2) · Karabuk University (2) · Nathalie Charpak (2) · Muhammad Aamir Latif (2)

What is being tested here

Drugs under test in Hyperbilirubinemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fenofibrate111
Tin mesoporphyrin014
Cholecalciferol001
Dexamethasone011
Immunoglobulins, Intravenous001
Immunoglobulin G001
Gluconic acid001
Carnitine001

Coming up

1phase 3 study under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 9 Hyperbilirubinemia studies recruiting now, 1 (11%) set no upper age limit and 7 (78%) stop at 75 or younger. 8 (89%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (44%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
100 (0%)0 (0%)
183 (33%)3 (33%)
302 (22%)2 (22%)
402 (22%)2 (22%)
502 (22%)2 (22%)
652 (22%)2 (22%)
752 (22%)2 (22%)
851 (11%)1 (11%)

Across all 81 studies, recruiting or not: 84% stop at 75 or younger and 83% at 65; 88% take children; 1% are for women only and 0% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperbilirubinemia studies take

Of 22 interventional studies with no phase under Hyperbilirubinemia, half reached primary completion within 9 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase9 mo5–19 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 → or search them.